MedPath
HSA Approval

BRUFEN Suspension 100 mg/5 ml

SIN05443P

BRUFEN Suspension 100 mg/5 ml

BRUFEN Suspension 100 mg/5 ml

February 19, 1991

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence HolderABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

M01AE01

ibuprofen

Manufacturer Information

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

PT. Abbott Indonesia

Active Ingredients

IBUPROFEN

100 mg/5 ml

Ibuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BRUFEN Suspension 100 mg/5 ml - HSA Approval | MedPath